Showing results (531-540 of 604) with videos related to
Sort By:
Pageof 61
Ecological Applications : a Publication of the Ecological Society of America|October 16, 2010
Conserving biodiversity in production landscapesK A Wilson, E Meijaard, S Drummond, et al.Biorxiv : the Preprint Server for Biology|November 24, 2025
Co-targeting menin and LSD1 dismantles oncogenic programs and restores differentiation in MLL-rearranged AMLMina M Tayari, Helena Gomes Dos Santos, Felipe Beckedorff, et al.Nature Communications|May 31, 2024
The chromatin landscape of pathogenic transcriptional cell states in rheumatoid arthritisKathryn Weinand, Saori Sakaue, Aparna Nathan, et al.Vector Borne and Zoonotic Diseases (Larchmont, N.Y.)|May 2, 2024
Evidence of SARS-CoV-2 Antibody in Mississippi White-Tailed DeerScoty Hearst, Pedro M Palermo, Douglas M Watts, et al.Journal of Strength and Conditioning Research|February 1, 2012
The effects of a customized over-the-counter mouth guard on neuromuscular force and power production in trained men and womenCourtenay Dunn-Lewis, Hui-Ying Luk, Brett A Comstock, et al.International Journal of Cancer|July 29, 2016
Informing etiologic research priorities for squamous cell esophageal cancer in Africa: A review of setting-specific exposures to known and putative risk factorsV A McCormack, D Menya, M O Munishi, et al.Frontiers in Pharmacology|August 16, 2024
Interaction of Acinetobacter sp. RIT 592 induces the production of broad-spectrum antibiotics in Exiguobacterium sp. RIT 594Anutthaman Parthasarathy, Renata Rezende Miranda, T J Bedore, et al.Endocrinology|January 24, 2009
Inhibition of protein tyrosine phosphatase-1B with antisense oligonucleotides improves insulin sensitivity and increases adiponectin concentrations in monkeysMichael M Swarbrick, Peter J Havel, Arthur A Levin, et al.Allergy and Asthma Proceedings|December 6, 2021
COVID-19 vaccine-related presumed allergic reactions and second dose administration by using a two-step graded protocolGayatri B Patel, Krishan D Chhiba, Michael M Chen, et al.Vaccine|March 30, 2010
Inactivated yellow fever 17D vaccine: development and nonclinical safety, immunogenicity and protective activityThomas P Monath, Cynthia K Lee, Justin G Julander, et al.Pageof 61